HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches
- 1 December 1999
- journal article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 5 (4), 357-382
- https://doi.org/10.1016/s1071-9164(99)91340-4
Abstract
No abstract availableThis publication has 108 references indexed in Scilit:
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Risk of arterial ambolization in 224 patients awaiting cardiac transplantationAmerican Heart Journal, 1995
- A Prospective, Randomized, Controlled Trial of Prednisone for Dilated CardiomyopathyNew England Journal of Medicine, 1989
- A Comparison of Oral Milrinone, Digoxin, and Their Combination in the Treatment of Patients with Chronic Heart FailureNew England Journal of Medicine, 1989
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Active Myocarditis in the Spectrum of Acute Dilated CardiomyopathiesNew England Journal of Medicine, 1985
- Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.Circulation, 1981
- Vasodilator Therapy for Heart FailureCirculation, 1973
- Hormones and the Pathogenesis of Congestive Heart Failure:Vasopressin, Aldosterone, and Angiotensin IICirculation, 1962